PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
Turnover
16.67%
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+10.28%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$7.07M
(+6.8%)
Cap. Flow
+$1.09M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
37.5%
Holding
131
New
20
Increased
38
Reduced
36
Closed
14
Avg Time Held
2
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPS Commerce
SPSC
|
+$1.13M |
| 2 |
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
|
+$1.04M |
| 3 |
IVTY
Invuity, Inc
IVTY
|
+$996K |
| 4 |
Tile Shop Holdings
TTSH
|
+$902K |
| 5 |
CRZO
Carrizo Oil & Gas Inc
CRZO
|
+$692K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axogen
AXGN
|
+$2.02M |
| 2 |
AbbVie
ABBV
|
+$1.96M |
| 3 |
Integer Holdings
ITGR
|
+$1.45M |
| 4 |
Cogentix Medical, Inc.
CGNT
|
+$1.37M |
| 5 |
Altria Group
MO
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.48% |
| 2 | Technology | 13.38% |
| 3 | Industrials | 9.54% |
| 4 | Energy | 4.99% |
| 5 | Financials | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Axogen
AXGN
$2.07B
| $15.6M | 14.07% |
428,250
-65,900
| -13% | -$2.02M |
2013 Q3
18 quarters
|
|
2
Vericel Corp
VCEL
$2.05B
| $5.42M | 4.88% |
544,950
-34,000
| -6% | -$281K |
2014 Q3
14 quarters
|
|
3
Abbott
ABT
$178B
| $4.85M | 4.37% |
80,950
| – | – |
2014 Q1
16 quarters
|
|
4
Idexx Laboratories
IDXX
$41.5B
| $2.56M | 2.3% |
13,350
| – | – |
2013 Q3
18 quarters
|
|
5
NeoGenomics
NEO
$2.16B
| $2.39M | 2.15% |
292,850
-5,000
| -2% | -$40.5K |
2013 Q2
19 quarters
|
|
6
LeMaitre Vascular
LMAT
$1.88B
| $2.38M | 2.15% |
65,800
-2,900
| -4% | -$100K |
2017 Q1
4 quarters
|
|
7
Pfizer
PFE
$167B
| $2.29M | 2.06% |
67,950
+6,888
| +11% | +$237K |
2013 Q2
19 quarters
|
|
8
Rockwell Medical
RMTI
$31M
| $2.21M | 1.99% |
3,865
-52
| -1% | -$32.8K |
2013 Q2
19 quarters
|
|
9
Microsoft
MSFT
$3.96T
| $1.99M | 1.79% |
21,810
+750
| +4% | +$68.6K |
2014 Q1
16 quarters
|
|
10
Eli Lilly
LLY
$1.08T
| $1.92M | 1.73% |
24,810
+3,910
| +19% | +$315K |
2013 Q2
19 quarters
|
|
11
Digital Turbine
APPS
$1.16B
| $1.83M | 1.65% |
911,975
-2,505
| -0.3% | -$5.44K |
2015 Q1
12 quarters
|
|
12
Tactile Systems Technology
TCMD
$504M
| $1.62M | 1.46% |
50,924
+17,174
| +51% | +$531K |
2017 Q4
1 quarter
|
|
13
Aflac
AFL
$59.2B
| $1.59M | 1.43% |
36,400
+2,000
| +6% | +$88.5K |
2015 Q2
11 quarters
|
|
|
VYNT
14
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $1.59M | 1.43% |
6,424
-174
| -3% | -$49K |
2015 Q4
9 quarters
|
|
15
ANI Pharmaceuticals
ANIP
$1.61B
| $1.57M | 1.42% |
27,000
| – | – |
2017 Q1
4 quarters
|
|
16
DELISTED
Profire Energy, Inc
PFIE
| $1.54M | 1.39% |
564,381
-5,100
| -0.9% | -$11.6K |
2016 Q2
7 quarters
|
|
17
AtriCure
ATRC
$2.91B
| $1.47M | 1.33% |
71,750
-16,800
| -19% | -$303K |
2013 Q2
19 quarters
|
|
|
TEUM
18
DELISTED
Pareteum Corporation
TEUM
| $1.4M | 1.26% |
573,229
+19,750
| +4% | +$47.7K |
2017 Q1
4 quarters
|
|
19
Blackstone
BX
$79.3B
| $1.36M | 1.23% |
42,650
+13,000
| +44% | +$443K |
2017 Q1
4 quarters
|
|
|
BBQ
20
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $1.36M | 1.22% |
191,600
+4,000
| +2% | +$26.7K |
2016 Q4
5 quarters
|
|
21
Ring Energy
REI
$339M
| $1.36M | 1.22% |
94,625
+7,900
| +9% | +$115K |
2017 Q3
2 quarters
|
|
22
Bristol-Myers Squibb
BMY
$121B
| $1.34M | 1.2% |
21,125
+950
| +5% | +$61.1K |
2017 Q3
2 quarters
|
|
|
CSII
23
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.33M | 1.2% |
60,800
-200
| -0.3% | -$4.81K |
2013 Q2
19 quarters
|
|
24
Target
TGT
$70.4B
| $1.3M | 1.17% |
18,700
| – | – |
2017 Q4
1 quarter
|
|
|
25
SPS Commerce
SPSC
$3.06B
| $1.28M | 1.15% |
+40,000
| New | +$1.13M |
2018 Q1
0 quarters
|
|
Similar funds
AA
WA
AC
BCVI
HAP
RHIG
CWM
SI
Perkins Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Perkins Capital Management held 131 positions worth $111M, up 6.8% from $104M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Perkins Capital Management's Q1 2018 filing shows 20 new, 38 increased, 36 reduced and 14 closed positions. Its largest new stake was SPS Commerce: 40,000 shares worth $1.28M. The largest sale was Axogen, an estimated $2.02M.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 60% a quarter earlier, followed by Technology and Industrials.
- Perkins Capital Management's largest Q1 2018 buy was SPS Commerce: 40,000 shares worth $1.28M.
- Perkins Capital Management added most to Craft Brew Alliance, Inc. in Q1 2018, an estimated $568K increase.
- Perkins Capital Management's biggest Q1 2018 reduction was Axogen, cutting an estimated $2.02M.
- Perkins Capital Management fully exited AbbVie in Q1 2018, selling an estimated $1.96M.
- Perkins Capital Management's ten largest holdings make up 37% of its $111M portfolio in Q1 2018.
- Perkins Capital Management opened 20 new positions and closed 14 in Q1 2018.
- Perkins Capital Management's portfolio value rose 6.8% quarter-over-quarter to $111M.
Based on Perkins Capital Management's 13F filing for Q1 2018, filed 23 Apr 2018.